Overview of cancer research within CRIG
350+ researchers from 50+ research groups at UGent, UZ Gent and VIB-UGent
More than 50 CRIG group leaders heading their own research team constitute the core of 'Cancer Research Institute Ghent' and meet internal criteria regarding focus and output on cancer research. In addition, more than 300 CRIG members - from different research groups with specific expertise, and with different profiles (professors, clinicians, pre- and post-doctoral fellows, assistents, ...) define the multidisciplinary nature and inclusive character of CRIG.
Covering fundamental, translational and clinical cancer research
From synthesis and delivery of anti-cancer drugs, over cancer cell profiling and imaging, in vitro and in vivo model systems, up to clinical cancer research.
Cancer research at CRIG covers the whole spectrum from bench to bedside.
Multidisciplinary research: different cancer types across expertise domains
Collaboration across a wide spectrum of cancer types and expertise domains represents the multidisciplinary character of CRIG.
This type of research is accelerated by sharing expertise, technological platforms and resources.
Different cancer types
Here, you can find an overview of different cancer types that are studied within CRIG. Per cancer type, you can discover the research that is performed by CRIG group leaders and members.
- Bladder cancer
- Brain cancer
- Breast cancer
- Colon cancer
- Desmoid tumors
- Head and neck cancer
- Kidney cancer
- Liver cancer
- Lung cancer
- Melanoma / skin cancer
- Multiple myeloma
- Ovarian / cervical cancer
- Pancreatic cancer
- Peritoneal carcinomatosis
- Prostate cancer
- Testicular cancer
- Thyroid cancer
Different research domains
CRIG researchs groups have a wide variety of expertises, and focus on different research domains that are relevant in cancer research. Cancer research is accelerated by joining forces and cross-fertilization between different disciplines. Per discipline, you can discover the research that is performed by CRIG group leaders and members.
- Cancer cell biology
- Cancer cell development (stem cells, ...)
- Cancer diagnostics, detection and prognosis
- Cancer drug discovery and delivery
- Cancer immunology and immunotherapy
- Cancer –omics (genomics, epigenomics, transcriptomics, proteomics)
- Clinical cancer research
- Patient treatment and care
- Preclinical evaluation of cancer drugs
- Screening, etiology and prevention
- Technology development
- Tumor micro-environment and signaling
(banner photography credits: Kimberly Verniers, CRIG member)